Iowa Oncology Research Association

爱荷华州肿瘤学研究协会

• 批准号: 7844988
• 负责人: Robert J. Behrens
• 金额: $ 68.55万
• 依托单位: IOWA ONCOLOGY RESEARCH ASSOCIATION
• 依托单位国家: 美国
• 财政年份: 1995
• 资助国家: 美国
• 起止时间: 1995-06-01 至 2012-05-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/7844988
• 关键词: Address; Adult; Advocacy; American; Awareness; Breast Cancer Prevention; Cancer Center; Cancer Control; Cancer Patient; Cancer Prevention Trial; Cancer Trials Support Unit; Caring; Catchment Area; Caucasians; Caucasoid Race; Censuses; Children' s Oncology Group; Church; Cities; Clinical Oncology; Clinical Research; Clinical Research Associate; Clinical Treatment; Clinical Trials; Collaborations; Commerce; Communication; Communities; Community Outreach; Community Participation; Controlled Clinical Trials; Controlled Study; County; County Hospitals; Discipline; Disorder by Site; Eastern Cooperative Oncology Group; Enrollment; Family; Fostering; Future; Goals; Healthcare; Hospitals; Institution; Iowa; Letters; Life; Link; Localized Malignant Neoplasm; Malignant Childhood Neoplasm; Mammography; Medical; Medical Oncologist; Medical Oncology; Mind; Minority; Modeling; National Surgical Adjuvant Breast and Bowel Project; Nature; North Central Cancer Treatment Group; Oncology Group; Operative Surgical Procedures; P-2; Participant; Patients; Physicians; Population; Prevention; Procedures; Process; Prostate Cancer Prevention Trial; Protocols documentation; Provider; Radiation Oncology; Research; Research Personnel; Rural; Site; Southwest Oncology Group; Specialist; Time; Treatment Protocols; Urology; Woman; Work; abstracting; anticancer research; base; cancer care; cancer prevention; cancer therapy; cancer type; improved; medical specialties; member; multidisciplinary; oncology; operation; patient population; research study; rural area; urban area

DESCRIPTION (provided by applicant): The Iowa Oncology Research Association (IORA) is a multidisciplinary consortium of nine Iowa hospitals, fourteen surgical, medical and radiation oncology practices and 68 physicians. Six of the hospitals are located in Des Moines, one in Ames, one in Mason City and one in Ottumwa. The IORA has been a principal member of North Central Cancer Treatment Group (NCCTG) since 1979 and has secondary research bases with Eastern Cooperative Oncology Group (ECOG), National Surgical Adjuvant Breast and Bowel Project (NSABP) and Children's Oncology Group (COG). The IORA also actively participates in Cancer Trials Support Unit (CTSU) and Southwest Oncology Group (SWOG) prostate cancer prevention trials. The goals of IORA are: 1) Provide excellence in cancer care to patients and families through participation in high quality cancer research; 2) Increase participation in adult and pediatric cancer treatment and cancer control clinical trials. Several steps have been or will be implemented to accomplish this goal for the adult population. The primary change centers on the re-organization of the Des Moines staff with one CRA to be on site at two of the medical oncology offices. This arrangement will foster a more collaborative working relationship and generate significantly more referrals for both cancer treatment and cancer control studies; 3) Support the goals and work of research bases with involvement of IORA investigators and patient populations; 4) Increase public and professional awareness of clinical trials through community outreach efforts and collaboration with other medical providers in the community; 5) Increase community participation in prevention studies such as the upcoming NSABP P-4 Breast Cancer Prevention Study by building on successful recruitment and retention strategies implemented in previous cancer prevention studies; 6) Develop strategies to increase minority involvement in cancer research. IORA investigators will continue to offer treatment studies to their minority patient population, keeping in mind that Iowa is 95% Caucasian. For cancer prevention trials, this goal will be accomplished through collaboration with local minority advocacy groups and health care institutions with high minority patient populations. The IORA has a proven track record as an efficient and disciplined team from four strategically located Iowa communities. The organization is the link between clinical trials and a significant portion of the state of Iowa with a catchment area that includes 48 counties and 43% of the state's population. The IORA will continue to enthusiastically emphasize quality in its research efforts and actively pursue accrual.

描述（由申请人提供）：爱荷华州肿瘤研究协会（IORA）是一个由九家爱荷华州医院，十四家外科手术，医学和放射肿瘤学实践以及68位医生组成的多学科财团。其中六家医院位于得梅因（Des Moines），一家位于埃姆斯（Ames），一家位于梅森市（Mason City），一家在奥图姆瓦（Ottumwa）。 IORA自1979年以来一直是北中央癌症治疗组（NCCTG）的主要成员，并与东部合作肿瘤学小组（ECOG），国家手术辅助乳腺乳腺癌和肠道项目（NSABP）和儿童肿瘤学集团（COG）拥有二级研究基础。 IORA还积极参与癌症试验支持单位（CTSU）和西南肿瘤学组（SWOG）前列腺癌预防试验。 IORA的目标是：1）通过参与高质量的癌症研究，为患者和家庭提供卓越的癌症护理； 2）增加参与成人和小儿癌症治疗以及癌症控制临床试验的参与。已经或将要实施几个步骤，以实现成人人群的目标。主要变革集中在得梅因工作人员重组，其中一个CRA将在两个医学肿瘤科办公室现场。这种安排将促进更加协作的工作关系，并为癌症治疗和癌症控制研究产生更多的推荐。 3）通过IORA研究人员和患者人群的参与来支持研究基础的目标和工作； 4）通过社区推广工作以及与社区其他医疗提供者的合作，提高公众和专业对临床试验的认识； 5）增加社区参与预防研究，例如即将进行的NSABP P-4乳腺癌预防研究，通过在先前的癌症预防研究中实施的成功招募和保留策略来建立； 6）制定策略以增加少数群体参与癌症研究。 IORA调查人员将继续为少数族裔患者人群提供治疗研究，并记住爱荷华州的95％高加索人。对于预防癌症试验，将通过与少数族裔患者人群的当地少数民族倡导组织和医疗机构的合作来实现此目标。 IORA作为一个有效且纪律严明的团队具有来自战略性地位于爱荷华州的四个社区的良好和纪律严明的团队。该组织是临床试验与爱荷华州大部分地区之间的联系，其中包括48个县和该州人口的43％之间的集水区。 IORA将继续热情地强调其研究工作的质量，并积极追求应计。